FAS gene expression, prognostic significance and molecular interactions in lung cancer

• Published in: Frontiers in oncology Vol. 14; p. 1473515
• Main Authors: Li, Kaimin, Tan, Shing Cheng, Yang, Zhihao, Li, Chenwei
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 02-10-2024
• Subjects: apoptosis; bioinformatics; data mining; FAS; in silico; lung carcinoma; Oncology; FAS; apoptosis; in silico; lung carcinoma; data mining; bioinformatics
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2024.1473515

FAS has been implicated in the development of various cancers, but its involvement in lung cancer has not been systematically characterized. In this study, we performed data mining in online tumor databases to investigate the expression, methylation, alterations, protein interactions, co-expression and prognostic significance of FAS in lung cancer.
The expression, prognostic significance and molecular interactions of FAS in lung cancer was mined and analyzed using GENT2, GEPIA2, UALCAN, cBioPortal, STRING, GeneMANIA, UCSC Xena, Enrichr, and OSluca databases. FAS expression was subsequently investigated at the protein level in samples from 578 lung cancer patients to understand its protein-level expression.
validation of FAS gene expression was performed on H1299, H1993, A549 and HBE cell lines.
We found that the expression of FAS was significantly downregulated in both lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) compared to normal lung tissue. In addition, we observed a higher level of FAS promoter methylation in LUSC tissue than in normal tissue. FAS alterations were rare (1.9%) in lung cancer samples, with deep deletions being more common than missense mutations, which occurred mainly in the TNFR-like cysteine-rich domain and the death domain. We also identified a list of proteins interacting with FAS and genes co-expressed with FAS, with LUAD having 11 co-expressed genes and LUSC having 90 co-expressed genes. Our results also showed that FAS expression has limited prognostic significance (HR=1.302, 95% CI=0.935-1.139, P=0.530). Protein level investigation revealed that FAS expression varied among individuals, with nTPM values ranging from 5.2 to 67.2.
This study provides valuable insights into the involvements and characteristics of FAS in lung cancer. Further studies are needed to investigate the clinical significance of FAS alterations in lung cancer and to explore the potential of targeting FAS for therapeutic intervention.